首页> 美国卫生研究院文献>BMC Infectious Diseases >Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report
【2h】

Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report

机译:成功的抗生素治疗脓肿分枝杆菌亚种引起的肺部疾病。 erm(41)基因19位C-T突变脓肿:病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMycobacterium abscessus complex (MABC) is the most drug resistant of the mycobacterial pathogens. M. abscessus subsp. abscessus encodes a functional erythromycin ribosomal methylase gene, erm(41), causing inducible macrolide resistance. However, some clinical isolates of M. abscessus subsp. abscessus harboring nonfunctional erm(41) were susceptible to macrolide, even after extended incubation of 14 days. Loss of function of the erm(41) genes was associated with a T-to-C substitution at position 28 of the gene (T28C), leading to an amino acid change from Trp to Arg at codon 10. Pulmonary disease caused by M. abscessus subsp. abscessus strains with an nonfunctional erm(41) (C28 sequevar) may be responsive to macrolide-containing antibiotic regimens. Therefore, all M. abscessus subsp. abscessus strains with a functional erm(41) (T28 sequevar) were thought to be resistant to macrolide with extended incubation. Here, we report the first case of pulmonary disease caused by a strain of M. abscessus subsp. abscessus which was susceptible to macrolide due to T19 sequevar of erm(41) gene.
机译:背景脓肿分枝杆菌复合物(MABC)对分枝杆菌病原体具有最高的耐药性。脓肿亚种脓肿编码功能性红霉素核糖体甲基化酶基因erm(41),引起可诱导的大环内酯类药物耐药。但是,脓肿分枝杆菌亚种的某些临床分离株。即使长时间孵育14天,带有非功能性erm(41)的脓肿也容易受到大环内酯类药物的影响。 erm(41)基因的功能丧失与该基因(T28C)位置28的T到C替换有关,导致第10位密码子的氨基酸从Trp变为Arg。脓肿亚种具有非功能性erm(41)(C28 sequevar)的脓肿菌株可能对含大环内酯类抗生素的治疗方案有反应。因此,所有脓肿亚种。具有功能性erm(41)(T28 sequevar)的脓肿菌株经延长孵育后可抵抗大环内酯类药物。在这里,我们报告了由脓肿分支杆菌亚种引起的首例肺部疾病。脓肿,是由于 erm (41)基因的T19序列形成而易患大环内酯类的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号